StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pfizer (PFE) Reaches Global Agreement with AbbVie (ABBV) on Adalimumab Biosimilar
November 30, 2018 10:01 AM
Pfizer Inc. (NYSE: PFE) today announced that it has signed licensing agreements with AbbVie (Nasdaq: ABBV) , resolving all global ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Litigation
Management Comments
Next Articles
AbbVie (ABBV) Reports New Data from Phase 3 MURANO Trial of VENCLEXTA/VENCLYXTO (venetoclax) in Combination with Rituximab
December 3, 2018 6:10 AM
Pfizer Reaches a Global Agreement with AbbVie
November 30, 2018 10:00 AM